NEUARTIGE VERBINDUNGEN

Patent europeic · EP2512242 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2512242
Numer da la dumonda
EP10838240
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
16-12-2010
Publitgà
24-10-2012
Concedì
30-09-2015
Stritgà
31-12-2015
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 495/04 (2006.01)
A61K 31/4365 (2006.01)
A61P 25/28 (2006.01)
Prioritad
US 287798 P 18.12.2009
Dumonda PCT
PCT/US2010/060696 16.12.2010
Publicaziun PCT
WO2011/075559 23.06.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-07-2016

    Stritgà, taxa betg pajada

    Published in Swissreg on 20.07.2016

  2. 30-09-2015

    Concedì

    Published in Swissreg on 30.09.2015

Partidas

Possessur

GlaxoSmithKline Intellectual Property Limited

980 Great West Road, Brentford, Middlesex TW8 9GS, GB

Inventur

CHEN, Deborah

Commonwealth 138667, SG

LEE, Kiew, Ching

Commonwealth 138667, SG

TERRELL, Lamont, Roscoe

PA 19406, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.